Literature DB >> 2731989

Identification of functional antigenic segments of toxic shock syndrome toxin 1 by differential immunoreactivity and by differential mitogenic responses of human peripheral blood mononuclear cells, using active toxin fragments.

C Edwin1, E H Kass.   

Abstract

When toxic shock syndrome toxin 1 was subjected to papain hydrolysis, two serologically active fragments of 16.3 kilodaltons (16K fragment) and 12.4 kilodaltons (12K fragment) were generated, whereas a third fragment of 9.7 kilodaltons (10K fragment) was inactive. The biologic activities of the fragments were evaluated in vitro by determining their ability to promote nonspecific proliferation of human peripheral blood mononuclear cells. The 12K fragment was significantly (P less than or equal to 0.013) more stimulatory than the 16K fragment. When human peripheral blood mononuclear cells were preincubated for a period of 24 h with various concentrations of the 16K fragment, followed by incubation with a constant amount (2 x 10(-2) ng/ml) of whole toxin, the level of DNA synthesis induced by the holotoxin was reduced by approximately 60% when compared with that of controls exposed to whole toxin alone. The 12K fragment did not demonstrate a similar blocking effect. Immunoblots of the toxic shock syndrome toxin 1 digest, which were exposed to monoclonal antibodies (MAbs) developed against native toxin, depicted the presence of two different antigenic regions (epitopes). One MAb, 8-5-7, which has been shown previously to inhibit the biologic activity of the holotoxin in vitro and in vivo, reacted primarily with the 12K fragment. A second MAb, 10-6-1, that did not neutralize interleukin-1 production reacted primarily with the 16K fragment. On the basis of the differential mitogenic responses and the identification of heterologous epitopes, it was concluded that the functional region of the holotoxin can be partitioned into at least two functional segments encompassed between amino acid residues 53 and 87 and between amino acid residues 88 and 194 on the polypeptide chain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2731989      PMCID: PMC313865          DOI: 10.1128/iai.57.7.2230-2236.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Protection of rabbits in an infection model of toxic shock syndrome (TSS) by a TSS toxin-1-specific monoclonal antibody.

Authors:  G K Best; D F Scott; J M Kling; M R Thompson; L E Adinolfi; P F Bonventre
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

2.  Nucleotide sequence of the type A staphylococcal enterotoxin gene.

Authors:  M J Betley; J J Mekalanos
Journal:  J Bacteriol       Date:  1988-01       Impact factor: 3.490

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS.

Authors:  P M Schlievert
Journal:  Lancet       Date:  1986-05-17       Impact factor: 79.321

6.  Structure-activity relationship of toxic-shock-syndrome toxin-1: derivation and characterization of immunologically and biologically active fragments.

Authors:  C Edwin; J Parsonnet; E H Kass
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

7.  Localization of biologic functions of toxic shock syndrome toxin-1 by use of monoclonal antibodies and cyanogen bromide-generated toxin fragments.

Authors:  D A Blomster-Hautamaa; R P Novick; P M Schlievert
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

8.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

Authors:  P M Schlievert; K N Shands; B B Dan; G P Schmid; R D Nishimura
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

9.  Induction of interleukin-1 by strains of Staphylococcus aureus from patients with nonmenstrual toxic shock syndrome.

Authors:  J Parsonnet; Z A Gillis; G B Pier
Journal:  J Infect Dis       Date:  1986-07       Impact factor: 5.226

10.  Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo.

Authors:  P F Bonventre; M R Thompson; L E Adinolfi; Z A Gillis; J Parsonnet
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

View more
  11 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Refined structures of three crystal forms of toxic shock syndrome toxin-1 and of a tetramutant with reduced activity.

Authors:  G S Prasad; R Radhakrishnan; D T Mitchell; C A Earhart; M M Dinges; W J Cook; P M Schlievert; D H Ohlendorf
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

Review 3.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

4.  Concomitant loss of conformation and superantigenic activity of staphylococcal enterotoxin B deletion mutant proteins.

Authors:  B Metzroth; T Marx; M Linnig; B Fleischer
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

5.  Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1.

Authors:  M L Hoffmann; L M Jablonski; K K Crum; S P Hackett; Y I Chi; C V Stauffacher; D L Stevens; G A Bohach
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody.

Authors:  L Blanco; E M Choi; K Connolly; M R Thompson; P F Bonventre
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

7.  Localization of a T-cell epitope of superantigen toxic shock syndrome toxin 1 to residues 125 to 158.

Authors:  W G Hu; X H Zhu; Y Z Wu; Z C Jia
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

Review 8.  The systemic and pulmonary immune response to staphylococcal enterotoxins.

Authors:  Sanjeev Kumar; Antoine Ménoret; Soo-Mun Ngoi; Anthony T Vella
Journal:  Toxins (Basel)       Date:  2010-07-21       Impact factor: 4.546

9.  Assessment of the functional regions of the superantigen staphylococcal enterotoxin B.

Authors:  Lily Zhang; Thomas J Rogers
Journal:  Toxins (Basel)       Date:  2013-10-22       Impact factor: 4.546

Review 10.  Basis of Virulence in Enterotoxin-Mediated Staphylococcal Food Poisoning.

Authors:  Emilie L Fisher; Michael Otto; Gordon Y C Cheung
Journal:  Front Microbiol       Date:  2018-03-13       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.